Study in subjects with anemia of chronic kidney disease to assess safety and efficacy of daprodustat compared to darbepoetin alfa

Mise à jour : Il y a 4 ans
Référence : EUCTR2016-000542-65

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

•To compare daprodustat to darbepoetin alfa for cardiovascular (CV) safety (non-inferiority) •To compare daprodustat to darbepoetin alfa for hemoglobin (Hgb) efficacy (non-inferiority)


Critère d'inclusion

  • Anemia associated with chronic kidney disease